Tanya Turan to Follow-Up Studies
This is a "connection" page, showing publications Tanya Turan has written about Follow-Up Studies.
Connection Strength
0.505
-
Relationship between risk factor control and vascular events in the SAMMPRIS trial. Neurology. 2017 Jan 24; 88(4):379-385.
Score: 0.086
-
Characterization of intracranial atherosclerotic stenosis using high-resolution MRI study--rationale and design. Brain Behav. 2015 Dec; 5(12):e00397.
Score: 0.079
-
Effect of dihydropyridine calcium channel blockers on blood pressure variability in the SPRINT trial: a treatment effects approach. J Hypertens. 2022 03 01; 40(3):462-469.
Score: 0.031
-
Maternal Coronary Heart Disease, Stroke, and Mortality Within 1, 3, and 5 Years of Delivery Among Women With Hypertensive Disorders of Pregnancy and Pre-Pregnancy Hypertension. J Am Heart Assoc. 2021 02; 10(5):e018155.
Score: 0.029
-
Endovascular repair compared with surveillance for patients with small abdominal aortic aneurysms. J Vasc Surg. 2010 May; 51(5):1081-7.
Score: 0.027
-
Characterization of Recurrent Strokes With and Without Patent Foramen Ovale Closure. J Am Coll Cardiol. 2018 11 13; 72(20):2542-2544.
Score: 0.024
-
Higher Stroke Risk with Lower Blood Pressure in Hemodynamic Vertebrobasilar Disease: Analysis from the VERiTAS Study. J Stroke Cerebrovasc Dis. 2017 Feb; 26(2):403-410.
Score: 0.021
-
Impact of the New American Heart Association/American Stroke Association Definition of Stroke on the Results of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. J Stroke Cerebrovasc Dis. 2017 Jan; 26(1):108-115.
Score: 0.021
-
Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial. JAMA Neurol. 2016 Mar; 73(3):308-15.
Score: 0.020
-
Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial. JAMA Neurol. 2016 Jan; 73(1):36-42.
Score: 0.020
-
Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial. Neurology. 2015 Dec 15; 85(24):2090-7.
Score: 0.020
-
Undifferentiated uterine carcinoma: analysis of eighteen cases. J Obstet Gynaecol. 2015 May; 35(4):372-6.
Score: 0.018
-
Racial differences in poststroke rehabilitation utilization and functional outcomes. Arch Phys Med Rehabil. 2015 Jan; 96(1):84-90.
Score: 0.018
-
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014 Jan 25; 383(9914):333-41.
Score: 0.017
-
Intracranial stenting: SAMMPRIS. Stroke. 2013 Jun; 44(6 Suppl 1):S41-4.
Score: 0.017
-
Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke. 2012 Oct; 43(10):2682-8.
Score: 0.016
-
Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial. J Neurointerv Surg. 2013 Nov; 5(6):528-33.
Score: 0.016
-
Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011 Sep 15; 365(11):993-1003.
Score: 0.015
-
Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology. 2007 Nov 27; 69(22):2063-8.
Score: 0.011